Copyright © 2021. Inderes Oyj. All rights reserved.

Physitrack

Analyytikko

Sisäpiirin kaupat

Nettovaikuttavuus

Tiedotteet
9.5.
2022

Physitrack PLC (publ) invites you to a webcast presentation of its acquisition of Champion Health, which was announced on May 6, 2022. The online presentation will take place today, May 9, 2022, at 10.00 CEST.

Speakers:
Henrik Molin, CEO and co-founder, Physitrack
Harry Bliss, CEO and co-founder, Champion Health
Charlotte Goodwin, CFO, Physitrack

Tiedotteet
6.5.
2022

Physitrack PLC (publ), a leader in the global digital health space, has today completed the acquisition of UK-based Champion Health Ltd (Champion), a leading workplace health platform based in the UK. Physitrack will pay a total cash consideration of GBP 2.5 million upfront for the acquisition, and a further potential aggregate earn-out consideration of up to GBP 7.894 million over four years, subject to Champion achieving stretching growth and profitability targets in that period.

Tiedotteet
5.5.
2022

Physitrack PLC has adjusted its previously communicated financial calendar for 2022, where the date for publication of the Q1 interim report has been moved to 25 May 2022.

Tiedotteet
3.5.
2022

At the Annual General Meeting (the AGM) of Physitrack PLC (“Physitrack” or the “Company”), on 3 May 2022, the following resolutions were adopted.

To receive and adopt the Annual Report and Accounts

The AGM resolved to receive and adopt the Company’s Annual Report and Accounts for the period ended 31 December 2021, together with the reports of the Directors and Auditor.

Re-election of Directors

Tiedotteet
2.5.
2022

Physitrack is ranked as #2 among listed Nordic companies for growth efficiency, with an E40 of 112,38%, according to a new report by the software company Upsales. E40 is a KPI that balances revenue growth against profitability and has been widely recognised as a way to determine the performance of SaaS companies.

Tiedotteet
4.4.
2022

This Notice of Annual General Meeting is an important document and requires your immediate attention. If you are in any doubt as to what action to take, you should consult your stockbroker, bank manager, solicitor, accountant and/or other appropriate independent professional adviser without delay.

Tiedotteet
17.3.
2022

Physitrack PLC (publ) has today published its Annual Report 2021.

Muut analyysit
7.3.
2022

SaaS platform with a range of solutions for physiotherapy Organic sales CAGR of 24% in ’20/’21-’24eShare price range: SEK 42-69, 11x-17x ’23e EV/EBITDARecurring revenues, strong growth and EBITDA marginPhysitrack provides a digital platform with a wi

Tiedotteet
24.2.
2022

Financial highlights for the quarter and thirteen month period ended 31 December 2021

Tiedotteet
23.2.
2022

Physitrack will pay a total cash consideration of EUR 2.5 million upfront for the acquisition, and a further potential aggregate earn-out consideration of up to EUR 9 million over four years, subject to Wellnow achieving stretching growth targets in that period that are in alignment with Physitrack’s.

Physitrack

ipo